Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $2450.0000 (3.59%) ($2410.0000 - $2450.0000) on Sat. Aug. 16, 2008. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.21% (three month average) | RSI | 66 | Latest Price | $2450.0000(3.59%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.6% a day on average for past five trading days. | Weekly Trend | CAPR advances 11.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting CAPR price | CAPR will decline at least -1.605% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.605% (StdDev 3.21%) | Hourly BBV | 0 () | Intraday Trend | 1.7% | | | |
|
5 Day Moving Average | $2463(-0.53%) | 10 Day Moving Average | $2375.52(3.14%) | 20 Day Moving Average | $2259.58(8.43%) | To recent high | -9.3% | To recent low | 30% | Market Cap | $N/A | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |